Internal mammary node irradiation
RadiationIrradiation of the internal mammary nodes in intercostal space 1-4.
Other names: IMNI
NCT Number: NCT06549920
The DBCG IMN study is a nationwide prospective population-based cohort study allocating node-positive breast cancer patients with right-sided tumors to internal mammary node irradiation (IMNI) and patients with left-sided tumors to no IMNI.
This study is active but is not currently recruiting participants.
Notify MeAll sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Irradiation of the internal mammary nodes in intercostal space 1-4.
Other names: IMNI
Time frame: 15-years.
Censored at end of study or by emigration.
Time frame: 15-years.
Censored at end of study or by emigration.
Time frame: 15-years.
Censored at end of study or by emigration. Death by any cause was regarded as competing event.
Danish Breast Cancer Cooperative Group
Other
Acronym: DBCG IMN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05038735
Breast Cancer, Breast Diseases
Sint-Niklaas, Oost Vlaanderen, Belgium
View Trial DetailsNCT02728076
Breast Cancer, Breast Diseases
Milwaukee, Wisconsin, United States
View Trial DetailsNCT05394259
Adenocarcinoma, Breast Cancer
Houston, Texas, United States
View Trial DetailsNCT01450020
Breast Cancer, Breast Diseases
Duarte, California, United States
View Trial Details